Clinical study on Vitiligo with Siddha drug Thuravadhi Chooranam

Phase II Clinical study on Venpulli (Vitiligo) with the evaluation of Siddha trial drug Thuravadhi Chooranam (Internal) in Children - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108109

Enrollment

Registered

2026-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Thuravadhi Chooranam (Internal): Thuravadhi Chooranam is given as internal medicine.Dose is fixed according to the pediatric age and BMI,BDS, After food with honey for 48 days Control I

Eligibility

Inclusion criteria

Inclusion criteria: Hypo-pigmented patches surrounded by hyperpigmented border present in any part of the body Presence of sensation

Exclusion criteria

Exclusion criteria: Albinism Piebaldism Depigmented patches occurred after burns Juvenile diabetes with vitiligo Loss of sensation

Design outcomes

Primary

Measure	Time frame
Reduction in the VASI SCORE is assessed by comparing the symptom parameters before and after treatment.Timepoint: 48 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr A Satheesh Kumar

Government Siddha Medical College, Arumbakkam, Chennai.

drsatheeshmd@gmail.com9962066694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026